Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cerebral Palsy Asthenia Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Hypertonia Movement Disorders Muscle Hypertonia Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Weakness

Age range

1 month–21 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University

Stanford, California, 94305, United States

About this study

Children ages newborn to 21 with a diagnosis of arm weakness, hypertonia, or hyperkinesia due to cerebral palsy will be recruited. A muscle that is either over-active or under-active will be selected for each child. The child will be provided with the device to wear for 1 month in order to call attention to the identified muscle. At the beginning and end of the month, reaching will be assessed using three-dimensional kinematic motion capture. The outcome measure will be the speed and curvature of reaching to a target in front of the child.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

weakness, hypertonia, or hyperkinetic disorder affecting one or both arms
reduced speed or quality of reaching

Exclusion criteria

any condition that would increase the risk of participation

Treatment and study plan

surface EMG biofeedback

Device

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Registry information

Important dates

Study start: 2007
Primary completion: 2009
First posted: May 14, 2007
Registry last updated: May 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed